Stephens assumed coverage on shares of Guardian Pharmacy Services (NYSE:GRDN – Free Report) in a research report sent to investors on Tuesday, MarketBeat.com reports. The firm issued an overweight rating and a $21.00 price target on the stock.
Other analysts have also recently issued research reports about the stock. Truist Financial assumed coverage on shares of Guardian Pharmacy Services in a research note on Monday. They set a “buy” rating and a $22.00 target price for the company. Raymond James started coverage on shares of Guardian Pharmacy Services in a research report on Monday. They set an “outperform” rating and a $21.00 price objective for the company.
View Our Latest Research Report on GRDN
Guardian Pharmacy Services Price Performance
Insider Activity
In other Guardian Pharmacy Services news, Director Thomas J. Salentine, Jr. acquired 35,714 shares of the company’s stock in a transaction on Friday, September 27th. The stock was acquired at an average price of $14.00 per share, for a total transaction of $499,996.00. Following the purchase, the director now directly owns 35,714 shares of the company’s stock, valued at $499,996. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Hedge Funds Weigh In On Guardian Pharmacy Services
A hedge fund recently bought a new stake in Guardian Pharmacy Services stock. Seven Grand Managers LLC purchased a new position in Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 149,700 shares of the company’s stock, valued at approximately $2,515,000. Seven Grand Managers LLC owned 0.24% of Guardian Pharmacy Services as of its most recent filing with the Securities and Exchange Commission (SEC).
Guardian Pharmacy Services Company Profile
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Further Reading
- Five stocks we like better than Guardian Pharmacy Services
- Why Are These Companies Considered Blue Chips?
- Maximize Portfolio Income with These 3 Dividend ETFs
- Dividend Capture Strategy: What You Need to Know
- Talen Energy: A Nuclear Power Stock That Can Keep Winning
- What Does a Stock Split Mean?
- Rocket Lab Stock Soars Higher: Can It Keep Climbing?
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.